Optimize Your Medical Device FDA Submissions with Imaging Analytics

Interview with Tim Kulbago, CEO of ImageIQ

Total review times for 510(k) submissions have increased by more than 55 percent since 2005 because of poor quality submissions by medical device manufacturers, according to a July 2011 FDA report. Tim Kulbago, President & CEO of ImageIQ, tells us how to increase funding and improve regulatory approvals with extremely powerful imaging data.

Interview Highlights with Tim Kulbago

  • How ImageIQ turns subjective opinion into hard data and visual results.
  • Examples of how imaging and analytics have made the difference in medical device approvals by the FDA.
  • Can image analytics really help to reduce the length and cost of pre-market approvals and enhance post-market surveillance?
  • Improving physician-adoption through enhanced image analytics.
  • Tim’s advice for other medical device doers.
Guest
Tim Kulbago
President and CEO of Image IQ

Tim Kulbago is the President and CEO of Image IQ, a Cleveland Clinic Innovations company that specializes in utilizing software engineering, high-resolution 2D/3D/4D imaging, and custom-tailored image analysis and visualization to support a vast array of biomedical preclinical and clinical specialties. Tim has over 14 years of experience in the medical imaging industry. Most recently he was responsible for two businesses within Merge Healthcare (NASDAQ: MRGE). Tim was formerly the Chief Technology Officer of RIS Logic, a Solon Ohio based start-up company which created an industry-leading information system for radiology practices. Before joining the medical industry, Tim spent several years as a Research Assistant at the Applied Research Laboratory at The Pennsylvania State University, developing virtual reality training and visualization systems. Tim holds a Bachelor of Science degree from John Carroll University in Cleveland Ohio with studies in Computer Science, Physics and Math, and was honored with their “Distinguished Physics Alumnus Award” in 2004. He has a Master’s Degree in Acoustics from The Pennsylvania State University.

Download a copy of the interview transcript right here.
Share:
Twitter
Facebook
LinkedIn
Email

Total review times for 510(k) submissions have increased by more than 55 percent since 2005 because of poor quality submissions by medical device manufacturers, according to a July 2011 FDA report. Tim Kulbago, President & CEO of ImageIQ, tells us how to increase funding and improve regulatory approvals with extremely powerful imaging data.

Interview Highlights with Tim Kulbago

  • How ImageIQ turns subjective opinion into hard data and visual results.
  • Examples of how imaging and analytics have made the difference in medical device approvals by the FDA.
  • Can image analytics really help to reduce the length and cost of pre-market approvals and enhance post-market surveillance?
  • Improving physician-adoption through enhanced image analytics.
  • Tim’s advice for other medical device doers.
Guest
Tim Kulbago
President and CEO of Image IQ

Tim Kulbago is the President and CEO of Image IQ, a Cleveland Clinic Innovations company that specializes in utilizing software engineering, high-resolution 2D/3D/4D imaging, and custom-tailored image analysis and visualization to support a vast array of biomedical preclinical and clinical specialties. Tim has over 14 years of experience in the medical imaging industry. Most recently he was responsible for two businesses within Merge Healthcare (NASDAQ: MRGE). Tim was formerly the Chief Technology Officer of RIS Logic, a Solon Ohio based start-up company which created an industry-leading information system for radiology practices. Before joining the medical industry, Tim spent several years as a Research Assistant at the Applied Research Laboratory at The Pennsylvania State University, developing virtual reality training and visualization systems. Tim holds a Bachelor of Science degree from John Carroll University in Cleveland Ohio with studies in Computer Science, Physics and Math, and was honored with their “Distinguished Physics Alumnus Award” in 2004. He has a Master’s Degree in Acoustics from The Pennsylvania State University.

Download a copy of the interview transcript right here.
Share:
Twitter
Facebook
LinkedIn
Email

You May Like These Articles

Premium

From Chaos to Order

The Journey of a Medtech CEO with Amplifi CEO Sean Morris

Sean Morris is a serial entrepreneur who began his career in medical device sales and rapidly ascended to running the Peripheral Vascular Division of AngioDynamics. Sean's career is a roadmap of determination, creativity, and a relentless pursuit of mechanical solutions to clinical problems. In this interview, Sean shares the story — from his first job selling medical devices for AngioDynamics to his current role as CEO of Amplifi, how his novel Vein Dilation System is poised to revolutionize dialysis patient care, and the many lessons he’s learned bringing innovative medtech products to market as a startup CEO.

Premium

How Data is Transforming Medtech

Interview with Avenda Health CEO Shyam Natarajan

Shyam Natarajan, founder and CEO of Avenda Health, started as an academic with a knack for the business side of healthcare. He now leads the charge in revolutionizing prostate cancer care. In this interview, we talk about what it really takes to understand the market need for your product or service, how prototypes can be incredibly helpful in convincing relevant parties, how Shyam approaches fundraising, and what to expect from medtech in the future given current technological advancements in growing fields like AI.

Premium

Medsider Mentors

Volume VI

In Medsider Mentors Volume VI, we’ve distilled key insights from founders and CEOs of some of the hottest medical device and health technology startups including LimFlow, Field Medical, Sinaptica, Spark Biomedical, InterShunt and many more.

View More Interviews
See the Playbooks

Join Medsider as a Free Subscriber

Subscribe to Medsider and get access to exclusive benefits for free. No spam, 100% privacy, and your email won’t be shared.